GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Price-to-Tangible-Book

Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Price-to-Tangible-Book : 0.29 (As of Oct. 09, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Price-to-Tangible-Book?

As of today (2024-10-09), Shenzhen Neptunus Interlong Bio-Technique Co's share price is HK$0.139. Shenzhen Neptunus Interlong Bio-Technique Co's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was HK$0.48. Hence, Shenzhen Neptunus Interlong Bio-Technique Co's Price to Tangible Book Ratio of today is 0.29.

The historical rank and industry rank for Shenzhen Neptunus Interlong Bio-Technique Co's Price-to-Tangible-Book or its related term are showing as below:

HKSE:08329' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.29   Med: 0.74   Max: 3.87
Current: 0.29

During the past 13 years, Shenzhen Neptunus Interlong Bio-Technique Co's highest Price to Tangible Book Ratio was 3.87. The lowest was 0.29. And the median was 0.74.

HKSE:08329's Price-to-Tangible-Book is ranked better than
97.99% of 844 companies
in the Drug Manufacturers industry
Industry Median: 2.465 vs HKSE:08329: 0.29

A closely related ratio is called PB Ratio. As of today, Shenzhen Neptunus Interlong Bio-Technique Co's share price is HK$0.139. Shenzhen Neptunus Interlong Bio-Technique Co's Book Value per Sharefor the quarter that ended in Jun. 2024 was HK$0.61. Hence, Shenzhen Neptunus Interlong Bio-Technique Co's P/B Ratio of today is 0.23.


Shenzhen Neptunus Interlong Bio-Technique Co Price-to-Tangible-Book Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Price-to-Tangible-Book Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.69 0.41 0.39 0.35

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.35 - 0.35 0.30

Competitive Comparison of Shenzhen Neptunus Interlong Bio-Technique Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Neptunus Interlong Bio-Technique Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Neptunus Interlong Bio-Technique Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Neptunus Interlong Bio-Technique Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Shenzhen Neptunus Interlong Bio-Technique Co's Price-to-Tangible-Book falls into.



Shenzhen Neptunus Interlong Bio-Technique Co Price-to-Tangible-Book Calculation

Shenzhen Neptunus Interlong Bio-Technique Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2024 )
=0.139/0.483
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Shenzhen Neptunus Interlong Bio-Technique Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Shenzhen Neptunus Interlong Bio-Technique Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Traded in Other Exchanges
N/A
Address
95 Queensway, 18th Floor, United Centre, Admiralty, Hong Kong, HKG
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sales of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines; and the Sales and distribution of medicines and healthcare products. The majority of revenue is generated from the Manufacturing and selling of medicines.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines